Solvotrin Therapeutics
Solvotrin Therapeutics develops and markets Active Iron, a range of iron supplements designed to be non-constipating and highly absorbable. The product line includes specialized formulations for women, pregnancy, athletic performance, and general energy needs. The company targets consumers experiencing fatigue and iron deficiency who require a gastrointestinal-friendly alternative to traditional iron medications.
Healthtech
Pharmaceuticals
Consumer Health
Nutraceuticals
Funding summary
- Total raised
- €6.7M
- Funding rounds
- 1
Investors in Solvotrin Therapeutics
Investors on record for Solvotrin Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Solvotrin Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors